55部大剧、3部短剧、六大板块——中央广播电视总台2026年度电视剧片单正式出炉。肖战《小城良 方》《谍报上不封顶》双剧入选，杨紫《玉兰花开君再来》《祯娘传》《生命树》三部作品亮相，而备 受瞩目的《三体》第二部《三体：大史》也位列其中，延续科幻荧幕热潮。 肖战主演的《小城良方》改编自小说《飞刀》，搭档倪大红，讲述天才医生返乡开启温暖治愈的市井故 事。另一部《谍报上不封顶》由正午阳光出品，聚焦地下党员在隐蔽战线的生死斗争，自《伪装者》十 年后，该团队能否再创谍战经典，令人期待。 肖战主演 的两部新剧海报 杨紫则携三部题材各异的作品登场：与欧豪合作的《玉兰花开君再来》刻画女性逆袭传奇；《祯娘传》 以徽墨传承为主线，演绎东方匠心；与胡歌主演的《生命树》跨越年代，讲述高原生态守护者的动人篇 章。 此外，《剑来》《漫长的余生》《群星》等多部重磅作品也出现在片单中，覆盖现实题材、历史传奇、 刑侦谍战、古装玄幻等多种类型，展现出总台在电视剧创作上的多元布局与品质追求。 附：2026年总台电视剧片单（按板块分类） "时代脉动·万千气象"板块（13部） 《冬去春来》 《小芳出嫁》 《永不妥协》 《狂流》 杨紫主演 的三部新剧海 ...

Core Insights - The series "赴山海" has become a new flow password in the internet space, marking a significant event in the drama market for the second half of 2025 [1] - Despite high initial viewership and popularity, the series has faced criticism regarding its quality, leading to a complex evaluation of the lead actor 成毅's ability to carry a show [3][12] - The phenomenon of "black-red" (negative publicity leading to increased attention) has emerged, indicating that the series' flaws have generated significant online discussion, overshadowing its actual quality [9][11] Group 1: Series Performance and Reception - "赴山海" achieved over 700 million views within 10 days of its release, topping the drama popularity charts for 10 consecutive days [1] - The lead actor 成毅's character has garnered over 200 million views on iQIYI, showcasing his significant role in driving the series' initial success [1] - However, the series has been criticized for its production quality, with common complaints about the plot, pacing, and technical errors, leading to a decline in audience reception [6][11] Group 2: Actor's Market Position and Future Projects - 成毅 is set to star in the upcoming series "两京十五日," indicating that despite the current setback, he continues to secure high-profile projects [3] - The market's perception of an actor's ability to carry a show has become increasingly complex, with traditional metrics of success being challenged [3][18] - The concept of "single-person approval" has emerged, where top actors can secure projects based on their individual influence, reflecting a shift in how projects are evaluated in the industry [20][22] Group 3: Industry Trends and Actor Dynamics - The dual nature of flow (popularity) and its backlash has created a cycle where actors can quickly rise and fall based on a single project's reception [11][12] - The industry is witnessing a trend where both flow actors and established talent must continuously prove their worth, as the market allows for limited mistakes [29] - The emergence of a new generation of actors who can balance both popularity and acting skills is reshaping the competitive landscape, with a focus on diverse roles and strong performances [30]

Core Viewpoint - The recent backlash against actor Xiao Zhan from his fans regarding the upcoming medical drama "Liu Yisheng Returns Home" highlights the challenges and sensitivities surrounding medical-themed productions in the current market [1][2]. Group 1: Industry Challenges - Medical dramas are notoriously difficult to produce, often resulting in poor quality due to a lack of understanding of medical practices and terminology by the creative teams [3][6]. - A survey conducted by a professional medical forum revealed that 85.8% of doctors identified errors in medical dramas, indicating a significant gap between medical accuracy and entertainment [4]. - The production of medical dramas faces logistical challenges, such as securing filming locations and medical equipment, which complicates the creation of realistic settings [6][8]. Group 2: Market Reception - The market response to medical dramas has been largely negative, with many past productions failing to resonate with audiences, leading to a decline in interest in the genre [9][11]. - Despite a resurgence of medical dramas post-pandemic, the quality of storytelling remains a concern, as even well-received shows struggle to achieve high viewership numbers [11][12]. - Recent medical dramas have not been able to attract significant audience engagement, with some shows recording average ratings as low as 0.2% [11]. Group 3: Future Prospects - There is a recognized need for compelling medical dramas that resonate with ordinary viewers, focusing on relatable human stories rather than glorifying the medical profession [15]. - The potential for future medical dramas exists as the industry moves towards greater industrialization and exploration of deeper narratives within the medical context [12][15].

Group 1 - Youku released its 2025 content lineup featuring over 200 series, with a strong focus on historical dramas and suspense series [1][3] - Notable titles include "Cang Hai Chuan," directed by Zheng Xiaolong and starring Xiao Zhan, which has already surpassed 3.6 million reservations on the platform [1] - The suspense genre is highlighted with 19 premium suspense dramas, including "Suspicion" and "Peeling the Onion," showcasing Youku's competitive strategy in the video platform market [3][5] Group 2 - The spy drama "Intelligence Uncapped," starring Xiao Zhan and produced by Hou Hongliang, is also part of the 2025 lineup [5] - Youku's suspense series have received high ratings, with several titles ranking in the top five for 2024, including "Bian Shui Wang Shi" and "Xue Mi Gong" [5] - The youth romantic drama "Nan Hong" has achieved significant viewership, topping various charts and accumulating over 1 billion views, indicating Youku's successful content strategy in the youth genre [5][6] Group 3 - The urban emotional drama "Man Hao De Ren Sheng" has seen a continuous increase in viewership ratings, resonating with audiences through its themes of marriage, career, and family relationships [6] - The 2025 lineup includes "Wo He Wo De Ming," adapted from a novel by Liang Xiaosheng, which is expected to generate significant discussion among viewers [6]

Core Insights - Youku announced a 2025 content slate featuring over 200 high-quality productions, with a strong focus on historical dramas and suspense series [1][3] - The platform's suspense genre is highlighted as a competitive area, with 19 premium suspense dramas included in the new slate [3] - Youku's recent youth contemporary drama "Nan Hong" achieved significant success, topping various charts and boosting app downloads by nearly 300% [4] Group 1: Historical Dramas - The historical drama "Cang Hai Chuan," directed by Zheng Xiaolong and starring Xiao Zhan, has garnered over 3.6 million reservations on Youku [1] - Another major historical production, "Chang An Er Shi Si Ji," features Cheng Yi and revolves around themes of revenge and intrigue in the context of the Tang dynasty [1] Group 2: Suspense Series - The suspense genre is a key focus for Youku, with the platform leading in both quantity and quality of suspense content in the market [3] - "Bian Shui Wang Shi," a recent hit, has become the highest-rated suspense drama on Douban for 2024, setting a high standard for upcoming releases [3] - The new suspense series "Xuan An," directed by the same director as "Bian Shui Wang Shi," explores themes of evil and redemption [3] Group 3: Youth Contemporary Dramas - Youku has consistently produced successful youth contemporary dramas over the past three years, with "Nan Hong" being the latest to achieve over 1 billion views [4] - The upcoming series "Ying Tao Hu Po," based on a popular novel, is highly anticipated and expected to continue the trend of successful youth content [4]